Особенности лёгочной артериальной гипертензии, ассоциированной с системной склеродермией: обзор литературы

Особенности лёгочной артериальной гипертензии, ассоциированной с системной склеродермией: обзор литературы

Автор: Юдкина Н.Н., Волков А.В.

Журнал: Евразийский кардиологический журнал @eurasian-cardiology-journal

Рубрика: Оригинальные статьи

Статья в выпуске: 4, 2015 года.

Бесплатный доступ

Обзор посвящён проблеме лёгочной артериальной гипертензии, ассоциированной с системной склеродермией. Представлены данные по распространенности, генетическим аспектам, особенностям клинической картины и диагностических алгоритмов, используемых для ранней диагностики этого тяжелого проявления системной склеродермии.

Системная склеродермия, лёгочная артериальная гипертензия

Короткий адрес: https://sciup.org/14342804

IDR: 14342804

Список литературы Особенности лёгочной артериальной гипертензии, ассоциированной с системной склеродермией: обзор литературы

  • Лёгочная гипертензия. Под редакцией И.Е. Чазовой и Т.В. Мартынюк. - М.: Практика, 2015.
  • Galiè N., Humbert M., Vachiery J.L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015 Oct;46(4):903-75.
  • Чазова И.Е., Авдеев С.Н., Царева Н.А., Волков А.В., Мартынюк Т.В., Наконечников С.Н. Клинические рекомендации по диагностике и лечению лёгочной гипертонии. Терапевтический Архив 2014; 9:4-23.
  • LeRoy E.C., Black C., Fleischmajer R. et. al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988 Feb;15(2):202-5.
  • Mayes M.D. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003 May;29(2):239-54.
  • Maricq H.R., Weinrich M.C., Keil J.E. et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum. 1989 Aug;32(8):998-1006.
  • Mukerjee D., St. George D., Knight C., Davar J., Wells A.U., Du Bois R.M. et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004;43:461-6.
  • Hachulla E., de Groote P., Gressin V. et al. Itinér AIR-Sclérodermie Study Group. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum. 2009;60 (6):1831-1839.
  • Волков А.В. Лёгочная артериальная гипертензия при системных заболеваниях соединительной ткани. Научно-практическая ревматология. 2015. № 1 (53). С. 69-77.
  • Galiè N., Manes A., Farahani K.V. et al. Pulmonary arterial hypertension associated to connective tissue diseases. Lupus. 2005;14(9):713-717.
  • Mukerjee D., St. George D., Coleiro B. et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62(11):1088-1093.
  • Koh E.T., Lee P., Gladman D.D., Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol. 1996;35(10):989-993.
  • Kawut S.M., Taichman D.B., Archer-Chicko C.L., Palevsky H.I., Kimmel S.E. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest. 2003;123(2):344-350.
  • Condliffe R., Kiely D.G., Peacock A.J., et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009; 179(2):151-157.
  • Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R. Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond Naden, Gabriela Riemekasten, Patricia Carreira, Armando Gabrielli, Oliver Distler, Jacob M. van Laar, Gabriele Valentini, Christopher P. Denton, Otylia Kowal-Bielecka, Murat Inanc, Yannick Allanore, Ulrich A. Walker, Ulf Müller-Ladner, Madelon Vonk, Laszlo Czirjak, Ariane Herrick, Stanislav Sierakowski, Douglas Veale, Lorinda Chung, Phillip Clements, Barry J. Fessler, Dan Furst, Serena Guiducci, Vivian Hsu, Maureen Mayes, Thomas A. Medsger, jr, Peter Merkel, Richard Silver, Virginia Steen, John Varga, David Collier, Mary Ell Csuka, Sergio Jimenez, Bashar Kahaleh, James R. Seibold, Robert Simms, Janet Pope. Classification Criteria for Systemic Sclerosis: An ACR-EULAR Collaborative Initiative. Arthritis Rheum. 2013 Nov; 65(11): 2737-2747.
  • Ami A. Shah, Fredrick M. Wigley, and Laura K. Hummers. Telangiectases in scleroderma: a potential clinical marcer of pulmonary arterial hypertension. J Rheumatol. 2010 January ; 37(1): 98-104.
  • D.N. Grigoryev, S.C. Mathai, M.R. Fisher, et al. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl Res. 2008 April ; 151(4): 197-207.
  • Bull T.M., Coldren C.D., Moore M., Sotto-Santiago S.M., Pham D.V., Nana-Sinkam S.P., Voelkel N.F., Geraci M.W. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;170(8):911-9.
  • Micah R. Fisher, Stephen C. Mathai, Hunter C. Champion., Reda E. Girgis at al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis & Reumatism Vol. 54., No 9., September 2006.,3043-3050.
  • McGoon M.D., Krichman A., Farber H.W., et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc. 2008;83(8):923-931
  • Тареев Е.М., Виноградова О.М., Насонова В.А., Гусева Н.Г. Коллагенозы. - М.: Медицина. 1965 г.
  • Hadi Poormoghim, Mary Lucas., Noreen Fertig, Thomas A. Medsger. Systemic sclerosis sine scleroderma. Demographic., clinical., and serologic features and survival in forty-eight patients. Arthritis & Reumatism Vol. 43., No 2., February 2000., 444-451.
  • Galiè N., Hoeper M.M., Humbert M., Torbicki A., Vachiery J.L., Barbera J.A., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)., endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J. 2009;30:2493-537.
  • Kowal-Bielecka O., Avouac J., Pittrow D., Huscher D., Behrens F., Denton C.P., et al. Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS Group. J Rheumatol. 2009;37:105-15.
  • Mathai S.C., Sibley C.T., Forfia P.R., Mudd J.O., Fisher M.R., Tedford R.J., et al. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol. 2011;38:2410-8.
  • Meune C., Avouac J., Airo’ P., Beretta L., Dieud P., Wahbi K., et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum. 2011;63:2790-6.
  • Schreiber B.E., Valerio C.J., Keir G.J., Handler C., Wells A.U., Denton C.P., et al. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests. Arthritis Rheum. 2011;63:3531-9.
  • Thakkar V., Stevens M.W., Prior D., Moore O.A., Byron J., Liew D., et al. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Res Ther. 2012;14:R143-53.
  • Allanore Y., Borderie D., Avouac J., Zerkak D., Meune C., Hachulla E., et al. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum. 2008;58:284-91.
  • Thakkar V., Stevens W., Prior D., Youssef P., Liew D., Gabbay E., et al. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Res Ther. 2013;15:R193.
  • Coghlan J.G., Denton P.C., Grünig E., Bonderman D., Distler O., Khanna D., et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2013;00:1-10.
  • Yanjie Hao, Vivek Thakkar, Wendy Stevens., Kathleen Morrisroe, David Prior, Candice Rabusa, Peter Youssef, Eli Gabbay, Janet Roddy, Jennifer Walker, Jane Zochling, Joanne Sahhar, Peter Nash, Susan Lester, Maureen Rischmueller, Susanna M. Proudman, and Mandana Nikpourcorresponding author. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Res Ther. 2015; 17(1): 7.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp